Evidence map›Paper›PMID 31013249›Full record

ArticleBlood transfusion = Trasfusione del sangue2019

A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes.

Willy A Flegel, Thierry Peyrard, Jacques Chiaroni, Christophe Tournamille, Déborah Jamet, France Pirenne

Abstract readEditorialComment
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Proceed with care: the "uncommon" serologic weak D phenotypes.Blood transfusion = Trasfusione del sangue · 2021
    Article
  6. What constitutes the most cautious approach for a pregnant person with weak D type 4.0?CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
  7. Article
  8. Article
  9. Experience with RHD*weak D type 4.0 in the USA.Blood transfusion = Trasfusione del sangue · 2019
    Article
  10. Article
  11. Genotyping in Sickle Cell Disease Patients: The French Strategy.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Willy A FlegelDepartment of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, MD, United States of America.
Thierry PeyrardCentre National de Référence des Groupes Sanguins, INTS, Paris, France.
Jacques ChiaroniEtablissement Français du Sang, Marseille, France.
Christophe TournamilleEtablissement Français du Sang Île de France, Créteil, France.
Déborah JametEtablissement Français du Sang, Brest, France.
France PirenneEtablissement Français du Sang Île de France, Créteil, France.

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Black PeopleAllelesHaplotypesHumansPhenotypeTunisia

Identifiers

PMID31013249
PMCPMC6476736

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.